SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001169232-09-001037
Filing Date
2009-02-18
Accepted
2009-02-17 19:05:36
Documents
1
Group Members
CARLA.ZARATZIAN@CREDIT-SUISSE.COM

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 sunesispharm21309.htm SC 13G/A 51803
  Complete submission text file 0001169232-09-001037.txt   53979
Mailing Address PO BOX 900 ZURICH V8 CH 8070
Business Address PO BOX 900 FHLS ZURICH V8 CH 8070 41 1 212 16 16
CREDIT SUISSE/ (Filed by) CIK: 0000824468 (see all company filings)

IRS No.: 000000000
Type: SC 13G/A

Mailing Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080
Business Address 395 OYSTER POINT BOULEVARD SUITE 400 SOUTH SAN FRANCISCO CA 94080 650-266-3500
SUNESIS PHARMACEUTICALS INC (Subject) CIK: 0001061027 (see all company filings)

IRS No.: 943295878 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81034 | Film No.: 09616671
SIC: 2834 Pharmaceutical Preparations